Company Overview
Drug Delivery International Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Monday 19 July 2010, so this is a well established company. Drug Delivery International Limited has been in business for 15 years and 8 months. The accounts status is total exemption full and the accounts are next due on Monday 31 August 2026.
Registered Address

Bio Imaging Unit, Basement Medical Block Within Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameDRUG DELIVERY INTERNATIONAL LIMITED
Company NumberSC382118
Registered Office AddressBio Imaging Unit, Basement Medical Block Within Glasgow Royal Infirmary
 84 Castle Street
 G4 0SF
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date19/07/2010
Accounting Reference Date Day30
Accounting Reference Date Month11
Accounts Next Due Date31/08/2026
Accounts Last Made Up Date30/11/2024
Accounts Account CategoryTOTAL EXEMPTION FULL
Returns Next Due Date16/08/2016
Returns Last Made Up Date19/07/2015
Directors & Members
Show Resigned
Glenn Crocker - Director
(British, 62 years old, born March 1964)
Appointed 01 May 2022
 Active
Laura Gow - Director
(British, 42 years old, born July 1984)
Appointed 22 August 2022
 Active
Joanne Kelley - Director
(British, 67 years old, born October 1959)
Appointed 01 May 2022
 Active
Claire Madden-Smith - Director
(British, 53 years old, born March 1973)
Appointed 01 May 2022
 Active
Howard Stevens - Director
(British, 82 years old, born March 1944)
Appointed 18 August 2010
 Active
Carol Thomson - Director
(British, 52 years old, born July 1974)
Appointed 18 August 2010
 Active
Secretaries
Show Resigned
Other Company Directorships
Glenn Crocker
AESICA FORMULATION DEVELOPMENT LIMITED
ALDERLEY ANALYTICAL LTD
ALDERLEY PARK VENTURES LIMITED
BDD PHARMA LTD
BIOCITY ALDERLEY LIMITED
BIOCITY GROUP LIMITED
BIOCITY INVESTMENTS LIMITED
BIOCITY LIMITED
BIOCITY NOTTINGHAM LIMITED
BIOCITY SCOTLAND LIMITED
BIOHUB AT ALDERLEY LIMITED
BIOHUB LIMITED
BIO-IMAGES DRUG DELIVERY LTD
EMB LIMITED
INTELLIGENT OMICS LIMITED
MEDICITY LIMITED
MEDICITY NOTTINGHAM LIMITED
MEDILINK EAST MIDLANDS LIMITED
THE RENEWAL TRUST
THE UNITED KINGDOM SCIENCE PARK ASSOCIATION
TRANSDERMAL DIAGNOSTICS LTD
Laura Gow
BDD PHARMA LTD
BIO-IMAGES DRUG DELIVERY LTD
Joanne Kelley
1NHALER LTD
ALDERLEY PARK VENTURES LIMITED
BDD PHARMA LTD
BIO-IMAGES DRUG DELIVERY LTD
DARA HOUSE CONSULTANCY LIMITED
MICREGEN LTD
THE UNIVERSITY OF MANCHESTER INNOVATION CENTRE LIMITED
UNIVERSITY OF MANCHESTER INNOVATION FACTORY LIMITED
Claire Madden-Smith
BDD PHARMA LTD
BIO-IMAGES DRUG DELIVERY LTD
Howard Stevens
ACADEMY OF PHARMACEUTICAL SCIENCES
BDD PHARMA LTD
BIO-IMAGES DRUG DELIVERY LTD
CATALENT U.K. SWINDON ZYDIS LIMITED
CRYSTALLOGRAFX LTD.
SINAERX LTD
Carol Thomson
BDD PHARMA LTD
BIO-IMAGES DRUG DELIVERY LTD
Balance Sheet Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Balance Sheet
Fixed Assets 945,329 945,329 992,665
Current Assets 95,874 95,874 107,085
Creditors Due Within One Year 636,874 636,874 580,109
Working Cap -541,000 -541,000 -473,024
Total Assets Less Current Liabilities 404,329 404,329 519,641
Long-term Liabilities 78,305 78,305 106,951
Net Assets 326,024 326,024 412,690
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 326,024 326,024 412,690
Common Size Financial Analysis Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Tangible Fixed Assets - - -
Fixed Assets 90.8% 90.8% 90.3%
Stocks Inventory - - -
Debtors 8.2% 8.2% 9.7%
Cash Bank In Hand 1.0% 1.0% 0.1%
Current Assets 9.2% 9.2% 9.7%
Creditors Due Within One Year 61.2% 61.2% 52.7%
Net Current Assets Liabilities -52.0% -52.0% -43.0%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 31.3% 31.3% 37.5%
Capital Employed - - -
Total Assets Less Current Liabilities 38.8% 38.8% 47.3%
Financial Ratio Analysis Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Liquidity Ratio 0.2 0.2 0.2
Solvency Ratio 1.5 1.5 1.6
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 3
Mortgages Outstanding 1
Mortgages Part Satisfied 0
Mortgages Satisfied 2
Assets and Debt Analysis Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Assets 1,041,203 1,041,203 1,099,750
Debt 715,179 715,179 687,060
Net Assets/Debt 326,024 326,024 412,690

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. The amount of net assets suggests sufficient cover for total debts and obligations for the size of the company inferred by the balance sheet.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. The amount of net assets suggests sufficient cover for total debts and obligations for the size of the company inferred by the balance sheet.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. The amount of net assets suggests sufficient cover for total debts and obligations for the size of the company inferred by the balance sheet.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around G4 0SF
BIO-IMAGES DRUG DELIVERY LTD
BIO IMAGING UNIT, BASEMENT MEDICAL BLOCK WITHIN GLASGOW ROYAL INFIRMARY, 84 CASTLE STREET, GLASGOW, G4 0SF
BDD PHARMA LTD
BIO IMAGING UNIT, BASEMENT MEDICAL BLOCK WITHIN GLASGOW ROYAL INFIRMARY, 84 CASTLE STREET, GLASGOW, G4 0SF
Document Filings
Confirmation statement made on 15 July 2025 with no updates
Memorandum and Articles of Association
Resolutions
Registration of charge SC3821180003, created on 28 April 2025
Satisfaction of charge SC3821180002 in full
Confirmation statement made on 19 July 2024 with no updates
Termination of appointment of Stephen Brown as a director on 31 December 2023
Confirmation statement made on 19 July 2023 with no updates
Satisfaction of charge 1 in full
Appointment of Dr Glenn Crocker as a director on 1 May 2022
Appointment of Mrs Laura Gow as a director on 22 August 2022
Director's details changed for Dr Carol Christine Thomson on 17 November 2022
Registered office address changed from Bio-Images Research Ltd within Glasgow Royal Infirmary 84 Castle Street Glasgow G4 0SF to Bio Imaging Unit, Basement Medical Block within Glasgow Royal Infirmary 84 Castle Street Glasgow G4 0SF on 29 November 2022
Director's details changed for Dr Claire Elizabeth Madden-Smith on 24 August 2022
Appointment of Ms Joanne Kelley as a director on 1 May 2022
Confirmation statement made on 19 July 2022 with updates
Appointment of Ms Claire Elizabeth Madden-Smith as a director on 1 May 2022
Appointment of Mr Stephen Brown as a director on 1 May 2022
Director's details changed for Dr Carol Christine Thomson on 1 May 2022
Confirmation statement made on 19 July 2021 with updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free